Targeting endoplasmic reticulum stress and protein misfolding in schizophrenia: the emerging promise of sigma-1 receptor agonists.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Psychopharmacology

• Publication date

  2025-11-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00213-025-06940-6PMID 41217487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effects of Antipsychotic Drugs and Non-Pharmacological Therapies on Schizophrenia

  2025cited by this paper
• Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat

  2025cited by this paper
• Sigma-1 Receptor Ligands for CNS Cancer Treatment

  2025cited by this paper
• Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders

  2025cited by this paper
• Sigma-1 Receptor Activation by Fluvoxamine Ameliorates ER Stress, Synaptic Dysfunction and Behavioral Deficits in a Ketamine Model of Schizophrenia

  2025cited by this paper
• Protein Misfolding and Aggregation as a Mechanistic Link Between Chronic Pain and Neurodegenerative Diseases

  2025cited by this paper
• Sigma-1 receptor modulation by fluvoxamine ameliorates valproic acid-induced autistic behavior in rats: Involvement of chronic ER stress modulation, enhanced autophagy and M1/M2 microglia polarization.

  2024cited by this paper
• Sigma-1 receptor recruits LC3 mRNA to ER-associated omegasomes to promote localized LC3 translation enabling functional autophagy.

  2024cited by this paper
• Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy

  2024cited by this paper
• Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

  2023cited by this paper
• Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review

  2023cited by this paper
• Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy

  2023cited by this paper
• The effects of sigma-1 agonist fluvoxamine on experimental induced tardive dyskinesia model in rats.

  2023cited by this paper
• Endoplasmic reticulum stress: molecular mechanism and therapeutic targets

  2023cited by this paper
• Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response

  2023cited by this paper
• The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy

  2023cited by this paper
• Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor.

  2023cited by this paper
• ERVW-1 Activates ATF6-Mediated Unfolded Protein Response by Decreasing GANAB in Recent-Onset Schizophrenia

  2023cited by this paper
• The essential functions of molecular chaperones and folding enzymes in maintaining endoplasmic reticulum homeostasis.

  2023cited by this paper
• Molecular Chaperones as Therapeutic Target: Hallmark of Neurodegenerative Disorders

  2023cited by this paper
• High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease

  2022cited by this paper
• Psychometric properties of the Stress and Anxiety to Viral Epidemics-9 scale among frontline nursing professionals working in the COVID-19 inpatients ward

  2022cited by this paper
• Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model

  2022cited by this paper
• The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia

  2022cited by this paper
• Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development

  2022cited by this paper
• Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders

  2022cited by this paper
• Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress

  2022cited by this paper
• Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia

  2022cited by this paper
• NOS1AP Interacts with α-Synuclein and Aggregates in Yeast and Mammalian Cells

  2022cited by this paper
• Cell Death Signaling From Endoplasmic Reticulum Stress: Plant-Specific and Conserved Features

  2022cited by this paper
• [Molecular Mechanisms of Interactions between Mitochondria and the Endoplasmic Reticulum: A New Look at How Important Cell Functions are Supported].

  2022cited by this paper
• Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists

  2022cited by this paper
• Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives

  2022cited by this paper
• Therapeutic Strategies Targeting Mitochondrial Calcium Signaling: A New Hope for Neurological Diseases?

  2022cited by this paper
• Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases

  2021cited by this paper
• Allosteric Modulation of the Sigma-1 Receptor Elicits Antipsychotic-like Effects.

  2021cited by this paper
• Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology

  2021cited by this paper
• The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate

  2021cited by this paper
• Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disorders

  2021cited by this paper
• Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy

  2021cited by this paper
• Protein Aggregation of NPAS3, Implicated in Mental Illness, Is Not Limited to the V304I Mutation

  2021cited by this paper
• The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s

  2021cited by this paper
• Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury

  2021cited by this paper
• Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats

  2020cited by this paper
• Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases

  2020cited by this paper
• The origin of NMDA receptor hypofunction in schizophrenia.

  2020cited by this paper
• Autophagy and Schizophrenia.

  2020cited by this paper
• Collapsin Response Mediator Proteins: Their Biological Functions and Pathophysiology in Neuronal Development and Regeneration

  2020cited by this paper
• Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques

  2020cited by this paper
• Sex Differences in Dendritic Spine Formation in the Hippocampus and Animal Behaviors in a Mouse Model of Hyperthyroidism

  2020cited by this paper
• The Unfolded Protein Response and Autophagy as Drug Targets in Neuropsychiatric Disorders

  2020cited by this paper
• PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation.

  2020cited by this paper
• The TRIOBP Isoforms and Their Distinct Roles in Actin Stabilization, Deafness, Mental Illness, and Cancer

  2020cited by this paper
• A comparative study of effectiveness, safety and cost effectiveness of olanzapine, risperidone and aripiprazole therapy in schizophrenia

  2020cited by this paper
• Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases

  2019cited by this paper
• Mutational Analysis of Sigma-1 Receptor’s Role in Synaptic Stability

  2019cited by this paper
• Dysregulation of the unfolded protein response (UPR) in the dorsolateral prefrontal cortex in elderly patients with schizophrenia

  2019cited by this paper
• SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance

  2019cited by this paper
• ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome.

  2019cited by this paper
• Glutamate modulators for treatment of schizophrenia

  2019cited by this paper
• Allosteric Modulators of Sigma-1 Receptor: A Review

  2019cited by this paper
• Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease

  2019cited by this paper
• A DISC1 point mutation promotes oligomerization and impairs information processing in a mouse model of schizophrenia

  2019cited by this paper
• Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.

  2019cited by this paper
• Collapsin response mediator protein 5 (CRMP5) causes social deficits and accelerates memory loss in an animal model of Alzheimer's disease.

  2019cited by this paper
• Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo

  2019cited by this paper
• Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors.

  2019cited by this paper
• Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells

  2019cited by this paper
• Sirtuin 1 and Autophagy Attenuate Cisplatin-Induced Hair Cell Death in the Mouse Cochlea and Zebrafish Lateral Line

  2019cited by this paper
• nNOS–CAPON interaction mediates amyloid‐β‐induced neurotoxicity, especially in the early stages

  2018cited by this paper
• Pridopidine Reverses Phencyclidine-Induced Memory Impairment

  2018cited by this paper
• Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications

  2018cited by this paper
• Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia/reperfusion injury

  2018cited by this paper
• Astrocytic Regulation of Glutamate Transmission in Schizophrenia

  2018cited by this paper
• Systematic Analysis of mRNA and miRNA Expression of 3D-Cultured Neural Stem Cells (NSCs) in Spaceflight

  2018cited by this paper
• Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases

  2018cited by this paper
• The interaction of NOS1AP, DISC1, DAOA, and GSK3B confers susceptibility of early‐onset schizophrenia in Chinese Han population

  2018cited by this paper
• Role of σ1 Receptors in Learning and Memory and Alzheimer's Disease-Type Dementia.

  2017cited by this paper
• Sigmar1 regulates endoplasmic reticulum stress-induced C/EBP-homologous protein expression in cardiomyocytes

  2017cited by this paper
• Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells.

  2017cited by this paper
• Dysbindin-1 Involvement in the Etiology of Schizophrenia

  2017cited by this paper
• Pathology of Neurodegenerative Diseases.

  2017cited by this paper
• Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

  2017cited by this paper
• Mitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases.

  2017cited by this paper
• The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases

  2017cited by this paper
• Carbon Catabolite Repression in Filamentous Fungi

  2017cited by this paper
• Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases

  2017cited by this paper
• An unpredicted aggregation-critical region of the actin-polymerizing protein TRIOBP-1/Tara, determined by elucidation of its domain structure

  2017cited by this paper
• NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness

  2017cited by this paper
• Fluoxetine-enhanced autophagy ameliorates early brain injury via inhibition of NLRP3 inflammasome activation following subrachnoid hemorrhage in rats

  2017cited by this paper
• Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches

  2017cited by this paper
• Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders.

  2017cited by this paper
• DISC1 Regulates the Proliferation and Migration of Mouse Neural Stem/Progenitor Cells through Pax5, Sox2, Dll1 and Neurog2

  2017cited by this paper
• Cocaine-Mediated Autophagy in Astrocytes Involves Sigma 1 Receptor, PI3K, mTOR, Atg5/7, Beclin-1 and Induces Type II Programed Cell Death

  2016cited by this paper
• Crystal structure of the human σ1 receptor

  2016cited by this paper
• Regulation of the actin cytoskeleton by the Ndel1-Tara complex is critical for cell migration

  2016cited by this paper
• The pathogenic mechanism of dysbindin-1B toxic aggregation: BLOC-1 and intercellular vesicle trafficking.

  2016cited by this paper
• The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress.

  2016cited by this paper
• A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation

  2016cited by this paper
• The integrated stress response

  2016cited by this paper

• No citing papers are available for this paper.